Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.40
-0.005-0.36%
Last update: Dec 15, 11:31 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Who are Macrogenics (MGNX) competitors?
Other companies in Macrogenics’s space includes: Outlook Therapeutics Inc (NASDAQ:OTLK), Fortress Biotech Inc (NASDAQ:FBIO), Tharimmune Inc (NASDAQ:THAR), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) and Coeptis Therapeutics Holdings Inc (NASDAQ:COEP).
What is the forecast, or price target, for Macrogenics (MGNX) stock?
Macrogenics has a consensus price target of $6.90.
What is the current price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $1.395 last updated December 15, 2025 at 11:31 AM EST.
Does Macrogenics (MGNX) pay a dividend?
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics does not have any upcoming earnings scheduled.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
